Lenacapavir, developed by U.S.-based Gilead Sciences, provides virtually 100% protection against HIV; activists slam Gilead’s patent filings, urge Indian regulators to waive requirement for local clinical trials
Djokovic's French Open future uncertain after stunning loss to Fonseca
Djokovic's French Open future uncertain after stunning loss to Fonseca Source: www.channelnewsasia.com





